Charming Medical advertises integrating Traditional Chinese Medicine wellness practices with modern technology. The class action alleges defendants made false or misleading statements or omitted that: (1) Charming Medical was the target of a fraudulent social-media stock-promotion scheme involving an impersonated financial professional; (2) insiders/affiliates used offshore or nominee accounts to coordinate share dumping during a price-inflation campaign; and (3) public statements and risk disclosures failed to disclose the false rumors and artificial trading. The complaint alleges trading was halted on November 12, 2025 after an SEC order that, according to the complaint, cited the social-media fraud.